Position in ENOV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,027,151
+$6,777,128 QoQ
Shares Held
528,666
+168.3% QoQ
Ownership
0.918%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENOV Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Man Group plc holds $734,341,087 across 40 Medical Devices names. ENOV ranks #11 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
3,718,731 | $233,350,370 | |
| 2 | PODD |
Insulet Corp
|
716,426 | $150,334,831 | |
| 3 | EW |
Edwards Lifesciences Corp
|
1,147,468 | $91,889,236 | |
| 4 | ABT |
Abbott Laboratories
|
363,904 | $37,362,023 | |
| 5 | MASI |
Masimo Corp
|
166,235 | $29,568,219 | |
| 6 | MDT |
Medtronic plc
|
330,889 | $28,671,531 | |
| 7 | PEN |
Penumbra Inc
|
74,670 | $24,519,387 | |
| 8 | DXCM |
Dexcom Inc
|
357,842 | $22,472,476 |
All Filings in ENOV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,027,151 | 528,666 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,250,023 | 197,073 | Shares | Defined | 2026-02-17 | |
| 2024-12-31 | $358,806 | 8,177 | Shares | Defined | 2025-02-14 | |
| 2024-03-31 | $1,517,472 | 24,299 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $524,851 | 9,369 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $2,589,485 | 40,385 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $899,006 | 16,807 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $860,815 | 16,084 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $988,477 | 21,456 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,869,285 | 33,987 | Principal | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||